Host: Madelaine A. Feldman, MD, FACR <br>


  
    <p>Coming to you from the Congress of Clinical Rheumatology’s Annual Meeting in Destin, Florida, Dr. Maddie Feldman investigates a new test that has the potential to help predict which rheumatoid arthritis patients will respond to anti-TNF therapies.</p>

Host: Madelaine A. Feldman, MD, FACR Coming to you from the Congress of Clinical Rheumatology’s Annual Meeting in Destin, Florida, Dr. Maddie Feldman investigates a new test that has the potential to help predict which rheumatoid arthritis patients will respond to anti-TNF therapies.

Precision Medicine in RA: A New Test for Predicting Anti-TNF Therapies

ReachMD brings you the latest research, announcements, and conversations from the most important medical conferences around the world. Join us on the conference floor with keynote speakers, experts, and opinion leaders.

Medicine

ReachMD brings you the latest research, announcements, and conversations from the most important medical conferences around the world. Join us on the conference floor with keynote speakers, experts, and opinion leaders.

ReachMD brings you the latest research, announcements, and conversations from the most important medical conferences around the world.&nbsp;Join us on the conference floor with keynote speakers, experts, and opinion leaders.

Share Precision Medicine in RA: A New Test for Predicting Anti-TNF Therapies

Sign up to save your podcasts

Precision Medicine in RA: A New Test for Predicting Anti-TNF Therapies

Precision Medicine in RA: A New Test for Predicting Anti-TNF Therapies

More shows like Conference Coverage

Medical Industry Feature

SexMed

Partners in Practice

Second Opinion LIVE!

Medical Breakthroughs from Penn Medicine

Advances in Women's Health

GI Insights